Metabolic & Weight
14 compound1s

Weight Loss & Metabolic Peptides for Research

The field of **metabolic peptide research** is currently one of the most dynamic and promising areas globally, offering profound insights into weight management and metabolic health. This collection focuses on cutting-edge compounds such as **GLP-1 receptor agonists**, including Semaglutide, Tirzepatide, Retatrutide, Survodutide, and Cagrilintide. These peptides primarily influence appetite regulation and insulin signalling, crucial pathways in metabolic control.

Beyond GLP-1s, our research collection also features **AMPK activators** like 5-Amino-1MQ and AICAR, which play a vital role in cellular energy sensing and metabolism. Additionally, we explore **fat-targeting peptides** such as AOD 9604, HGH Fragment 176-191, and Adipotide, which are being investigated for their potential in adipocyte apoptosis or lipolysis. Notably, Retatrutide stands out as the most advanced triple-agonist in this class, demonstrating significant research interest.

Understanding the mechanisms behind these peptides is key to advancing metabolic science. Whether you are new to peptide research or an experienced investigator, Pepnerd is committed to providing authoritative yet accessible resources. For more foundational knowledge, explore what peptides are and learn about peptide safety in research.

Begin Your Metabolic Research Journey

Explore our comprehensive range of research-grade metabolic peptides and contribute to the future of health science. All products are strictly for research purposes only.

Retatrutide
Metabolic
Retatrutide
Half-life
~6d
Delivery
SubQ injection
Typical dose
0.5mg
Triple agonist (GLP-1/GIP/Glucagon). Most potent weight loss peptide currently available. Phase 3...
AICAR
Growth recoveryMetabolic
AICAR
Half-life
~2-3h
Delivery
SubQ injection
Typical dose
150-500mg/day
AMPK activator. Mimics exercise at the cellular level by activating AMP-activated protein kinase....
MOTS-C
LongevityMetabolic
MOTS-C
Half-life
~2-4h
Delivery
SubQ injection
Typical dose
5-10mg
Mitochondria-derived peptide. Regulates metabolic homeostasis, improves insulin sensitivity, enha...
NAD+ (Injectable)
LongevityMetabolic
NAD+ (Injectable)
Half-life
~45min
Delivery
SubQ injection
Typical dose
250-500mg
Nicotinamide Adenine Dinucleotide. Essential coenzyme for cellular energy production, DNA repair,...
Tesamorelin
Growth recoveryMetabolic
Tesamorelin
Half-life
~26min
Delivery
SubQ injection
Typical dose
1-2mg
GHRH analogue. FDA-approved specifically to reduce visceral (abdominal) fat in HIV-associated lip...
5-Amino-1MQ
Metabolic
5-Amino-1MQ
Half-life
~2-3h
Delivery
SubQ injection
Typical dose
50-100mg/day
NNMT (nicotinamide N-methyltransferase) inhibitor. Increases cellular energy metabolism and fat b...
Adipotide
Metabolic
Adipotide
Half-life
~2-4h
Delivery
SubQ injection
Typical dose
0.5-1mg
Experimental fat-loss peptide. Targets blood vessels that supply white adipose (fat) tissue, caus...
HGH Fragment 176-191
Metabolic
HGH Fragment 176-191
Half-life
~15-30min
Delivery
SubQ injection
Typical dose
250-500mcg/day
The fat-burning fragment of human growth hormone. Same active sequence as AOD 9604. Stimulates li...
AOD 9604
Metabolic
AOD 9604
Half-life
~15-30min
Delivery
SubQ injection
Typical dose
250-500mcg/day
Modified fragment of HGH (amino acids 176-191). Specifically targets fat metabolism without the g...
Cagrilintide 5mg + Semaglutide 5mg (Blend)
BlendsMetabolic
Cagrilintide 5mg + Semaglutide 5mg (Blend)
Half-life
~7d each
Delivery
SubQ injection
Typical dose
Must titrate both
CagriSema combination. Dual-mechanism weight loss targeting both GLP-1 and amylin pathways simult...
Cagrilintide
Metabolic
Cagrilintide
Half-life
~7d
Delivery
SubQ injection
Typical dose
0.5mg
Long-acting amylin analogue. Reduces appetite through a different pathway than GLP-1 agonists. Be...
Survodutide
Metabolic
Survodutide
Half-life
~5-6d
Delivery
SubQ injection
Typical dose
0.5mg
Dual GLP-1/Glucagon agonist (different mechanism to tirzepatide which is GLP-1/GIP). Being studie...
Semaglutide
Metabolic
Semaglutide
Half-life
~7d
Delivery
SubQ injection
Typical dose
0.25mg
GLP-1 receptor agonist. FDA-approved as Ozempic (diabetes) and Wegovy (weight loss). The most wid...
Tirzepatide
Metabolic
Tirzepatide
Half-life
~5d
Delivery
SubQ injection
Typical dose
2.5mg
Dual GLP-1/GIP agonist. FDA-approved for type 2 diabetes (Mounjaro) and weight loss (Zepbound). P...
No compounds match the selected filters.